首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   11654篇
  免费   663篇
  国内免费   26篇
耳鼻咽喉   193篇
儿科学   626篇
妇产科学   150篇
基础医学   1424篇
口腔科学   196篇
临床医学   859篇
内科学   2352篇
皮肤病学   220篇
神经病学   720篇
特种医学   242篇
外科学   1878篇
综合类   277篇
一般理论   8篇
预防医学   770篇
眼科学   386篇
药学   1173篇
中国医学   55篇
肿瘤学   814篇
  2023年   82篇
  2022年   250篇
  2021年   465篇
  2020年   272篇
  2019年   348篇
  2018年   403篇
  2017年   259篇
  2016年   350篇
  2015年   382篇
  2014年   505篇
  2013年   574篇
  2012年   857篇
  2011年   868篇
  2010年   484篇
  2009年   418篇
  2008年   679篇
  2007年   685篇
  2006年   683篇
  2005年   560篇
  2004年   532篇
  2003年   465篇
  2002年   364篇
  2001年   205篇
  2000年   170篇
  1999年   156篇
  1998年   100篇
  1997年   61篇
  1996年   66篇
  1995年   39篇
  1994年   43篇
  1993年   57篇
  1992年   85篇
  1991年   66篇
  1990年   56篇
  1989年   88篇
  1988年   80篇
  1987年   53篇
  1986年   53篇
  1985年   43篇
  1984年   43篇
  1983年   50篇
  1982年   21篇
  1981年   22篇
  1980年   31篇
  1979年   25篇
  1975年   24篇
  1973年   29篇
  1972年   22篇
  1971年   20篇
  1970年   30篇
排序方式: 共有10000条查询结果,搜索用时 234 毫秒
1.
2.
3.
4.
5.
Esophageal adenocarcinoma is the fastest rising cancer in the United States. It develops from long‐standing gastroesophageal reflux disease which affects >20% of the general population. It carries a very poor prognosis with 5‐year survival <20%. The disease is known to sequentially progress from reflux esophagitis to a metaplastic precursor, Barrett''s esophagus and then onto dysplasia and esophageal adenocarcinoma. However, only few patients with reflux develop Barrett''s esophagus and only a minority of these turn malignant. The reason for this heterogeneity in clinical progression is unknown. To improve patient management, molecular changes which facilitate disease progression must be identified. Animal models can provide a comprehensive functional and anatomic platform for such a study. Rats and mice have been the most widely studied but disease homology with humans has been questioned. No animal model naturally simulates the inflammation to adenocarcinoma progression as in humans, with all models requiring surgical bypass or destruction of existing antireflux mechanisms. Valuable properties of individual models could be utilized to holistically evaluate disease progression. In this review paper, we critically examined the current animal models of Barrett''s esophagus, their differences and homologies with human disease and how they have shaped our current understanding of Barrett''s carcinogenesis.  相似文献   
6.
7.
Neurodegeneration with brain iron accumulation (NBIA) is the term applied to a heterogeneous group of disorders resulting in iron deposition in the basal ganglia. Well-known phenotypic features are progressive regression with extra pyramidal involvement and a variable course. A 10-year-old child born to consanguineous parents presented with progressive generalized opisthotonic dystonia, retrocollis, oromandibular dyskinesias, apraxia for swallowing, optic atrophy and severe self-mutilation of lips. MR imaging showed brain iron accumulation. Other causes of self-mutilation were excluded. Early infantile onset, ophisthotonic dystonia with oromandibular dyskinesias and characteristic MR images are suggestive of NBIA. There is only one case reported in the literature of self-mutilation in this condition.  相似文献   
8.

Purpose

A hydrogel rectal spacer (HRS) is a medical device that is approved by the U.S. Food and Drug Administration to increase the separation between the prostate and rectum. We conducted a cost-effectiveness analysis of HRS use for reduction in radiation therapy (RT) toxicities in patients with prostate cancer (PC) undergoing external beam RT (EBRT).

Methods and Materials

A multistate Markov model was constructed from the U.S. payer perspective to examine the cost-effectiveness of HRS in men with localized PC receiving EBRT (EBRT alone vs EBRT + HRS). The subgroups analyzed included site of HRS placement (hospital outpatient, physician office, ambulatory surgery center) and proportion of patients with good baseline erectile function (EF). Data on EF, gastrointestinal and genitourinary toxicities incidence, and potential risks associated with HRS implantation were obtained from a recently published randomized clinical trial. Health utilities and costs were derived from the literature and the 2018 Physician Fee Schedule and were discounted 3% annually. Quality-adjusted life years (QALYs) and costs were modeled for a 5-year period from receipt of RT. Probabilistic sensitivity analysis and value-based threshold analyses were conducted.

Results

The per-patient 5-year incremental cost for spacers administered in a hospital outpatient setting was $3578, and the incremental effectiveness was 0.0371 QALYs. The incremental cost-effectiveness ratio was $96,440/QALY for patients with PC undergoing HRS insertion in a hospital and $39,286/QALY for patients undergoing HRS insertion in an ambulatory facility. For men with good baseline EF, the incremental cost-effectiveness ratio was $35,548/QALY and $9627/QALY in hospital outpatient and ambulatory facility settings, respectively.

Conclusions

Based on the current Medicare Physician Fee Schedule, HRS is cost-effective at a willingness to pay threshold of $100,000. These results contain substantial uncertainty, suggesting more evidence is needed to refine future decision-making.  相似文献   
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号